Patients with high/very high disease status tended to have lower PRCA rates than those with low/Int disease status, but the difference ( P =0.099) did not reach statistical significance.
← all excerpts
Prevalence of Pure Red Cell Aplasia Following Major ABO-Incompatible Hematopoietic Stem Cell Transplantation.
2
—
—
The sentences
Previous studies have illustrated that the disappearance of anti-donor ISO was more effective in URD-HSCT rather than in MSD-HSCT (49 versus 166 days, P <0.001) ( 13 , 20 ), and the patients who underwent URD-HSCT showed a trend toward a lower incidence rate of post-HSCT PRCA compared to those who underwent MSD-HSCT ( 9 ).